{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:29:13Z","timestamp":1793834953419,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangzhou Science and Technology Plan Project","award":["202206080009"],"award-info":[{"award-number":["202206080009"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270975"],"award-info":[{"award-number":["82270975"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemoresistance to platinum-based agents like cisplatin is a major therapeutic challenge in advanced oral squamous cell carcinoma (OSCC), with 70\u201380% of recurrent cases developing resistance that severely compromises clinical outcomes. The mechanism of cisplatin resistance still remains unclear and requires further investigation. This study investigated ferroptosis suppression as a mechanism underlying this resistance and explored the therapeutic potential of the histone deacetylase (HDAC) inhibitor sodium butyrate (NaB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cisplatin-resistant OSCC cells (CAL27\/CDDP) and parental cells (CAL27) were used to assess ferroptosis levels and resistance mechanisms. The effects of NaB on reversing cisplatin resistance and inhibiting malignant behaviors (proliferation, migration, invasion) were evaluated in vitro. Mechanistic studies, including identification of key regulators and epigenetic modifications were conducted. The therapeutic effect was further validated in vivo using xenograft tumor models treated with NaB and cisplatin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CAL27\/CDDP exhibited significant ferroptosis suppression compared to CAL27. NaB effectively reversed cisplatin resistance and inhibited malignant behaviors in both cell lines. Mechanistic exploration revealed that NaB enhanced acetylation at the promoter region of early growth response protein 1 (EGR1) through HDAC9 inhibition, elevating its transcriptional activity. EGR1 functioned as a transcription factor to upregulate cytochrome P450 oxidoreductase (POR) expression, potentiating ferroptosis execution. In vivo experiments further confirmed the therapeutic relevance of this HDAC9\/EGR1\/POR signaling pathway, as NaB administration significantly sensitized xenograft tumors to cisplatin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings position NaB as a promising epigenetic modulator for overcoming cisplatin resistance in OSCC models, with immediate clinical implications. The identified pathway offers a redox biology-based therapeutic strategy that could be extended to other chemotherapy-resistant solid tumors, potentially revolutionizing the treatment paradigm for recurrent malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03663-0","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:52:29Z","timestamp":1771249949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uncovering a novel treatment strategy: sodium butyrate overcomes cisplatin resistance in the oral squamous cell carcinoma by inducing ferroptosis"],"prefix":"10.1186","volume":"45","author":[{"given":"Bing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangci","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinchao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"3","key":"3663_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","volume":"20","author":"JJ Caudell","year":"2022","unstructured":"Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, Colevas AD, Eisele DW, Galloway T, Geiger JL, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Mell LK, Mittal BB, Pinto HA, Rocco JW, Rodriguez CP, Savvides PS, Schwartz D, Shah JP, Sher D, St John M, Weber RS, Weinstein G, Worden F, Yang Bruce J, Yom SS, Zhen W, Burns JL, Darlow SD. NCCN Guidelines\u00ae insights: head and neck Cancers, version 1.2022. J Natl Compr Cancer Network: JNCCN. 2022;20(3):224\u201334.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"4","key":"3663_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Desai AP, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patel SP, Patil T, Polanco PM, Riess J, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hang L. Non-Small cell lung Cancer, version 4.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2024;22(4):249\u201374.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"12","key":"3663_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.6004\/jnccn.2019.0058","volume":"17","author":"T Gilligan","year":"2019","unstructured":"Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, Emamekhoo H, Feldman DR, Geynisman DM, Hancock SL, LaGrange C, Levine EG, Longo T, Lowrance W, McGregor B, Monk P, Picus J, Pierorazio P, Rais-Bahrami S, Saylor P, Sircar K, Smith DC, Tzou K, Vaena D, Vaughn D, Yamoah K, Yamzon J, Johnson-Chilla A, Keller J, Pluchino LA. Testicular Cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2019;17(12):1529\u201354.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"4","key":"3663_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","volume":"22","author":"TW Flaig","year":"2024","unstructured":"Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Buyyounouski MK, Chan K, Chang SS, Chang P, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kishan AU, Kundu S, Lele SM, Mamtani R, Mian OY, Michalski J, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Stewart T, Sundi D, Tollefson M, Tward J, Wright JL, Cassara CJ, Gurski LA. NCCN Guidelines\u00ae insights: bladder Cancer, version 3.2024. J Natl Compr Cancer Network: JNCCN. 2024;22(4):216\u201325.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"2","key":"3663_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA. Gastric Cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2022;20(2):167\u201392.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"5","key":"3663_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","volume":"20","author":"C Springfeld","year":"2023","unstructured":"Springfeld C, Ferrone CR, Katz MHG, Philip PA, Hong TS, Hackert T, B\u00fcchler MW, Neoptolemos J. Neoadjuvant therapy for pancreatic cancer. Nat Rev Clin Oncol. 2023;20(5):318\u201337.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"3663_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.34172\/joddd.2021.036","volume":"15","author":"F Atashi","year":"2021","unstructured":"Atashi F, Vahed N, Emamverdizadeh P, Fattahi S, Paya L. Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review. J Dent Res Dent Clin Dent Prospects. 2021;15(3):219\u201325.","journal-title":"J Dent Res Dent Clin Dent Prospects"},{"key":"3663_CR8","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, Mo Q, Zhao X, Fan Q, Deng F, Han C, Tan W. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2023;68:100938.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"issue":"15","key":"3663_CR9","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869\u201383.","journal-title":"Oncogene"},{"key":"3663_CR10","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, Cao C, Wang Q, Zhao X, Huang Z, Chen S, Chen H, Fan Q, Deng F, Hou L, Deng X, Tan W. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2024;73:101059.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"issue":"14","key":"3663_CR11","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"issue":"1","key":"3663_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hu J, Wu S, Fleishman JS, Li Y, Xu Y, Zou W, Wang J, Feng Y, Chen J, Wang H. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal Transduct Target Ther. 2023;8(1):449.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3663_CR13","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.7150\/thno.51797","volume":"11","author":"D Wang","year":"2021","unstructured":"Wang D, Zhao C, Xu F, Zhang A, Jin M, Zhang K, Liu L, Hua Q, Zhao J, Liu J, Yang H, Huang G. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through Exosomal PKM2. Theranostics. 2021;11(6):2860\u201375.","journal-title":"Theranostics"},{"issue":"1","key":"3663_CR14","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.1038\/s41467-024-52978-z","volume":"15","author":"V de Laat","year":"2024","unstructured":"de Laat V, Topal H, Spotbeen X, Talebi A, Dehairs J, Idkowiak J, Vanderhoydonc F, Ostyn T, Zhao P, Jacquemyn M, W\u00f6lk M, Sablina A, Augustyns K, Vanden Berghe T, Roskams T, Daelemans D, Fedorova M, Topal B, Swinnen JV. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nat Commun. 2024;15(1):8540.","journal-title":"Nat Commun"},{"issue":"4","key":"3663_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42(4):513\u201334.","journal-title":"Cancer Cell"},{"issue":"3","key":"3663_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, Sandoval-Gomez G, Clish CB, Doench JG, Schreiber SL. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16(3):302\u20139.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"3663_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Reviews Disease Primers. 2020;6(1):92.","journal-title":"Nat Reviews Disease Primers"},{"issue":"3","key":"3663_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"key":"3663_CR19","doi-asserted-by":"publisher","first-page":"217482","DOI":"10.1016\/j.canlet.2025.217482","volume":"614","author":"CS Wu","year":"2025","unstructured":"Wu CS, Li HP, Hsieh CH, Lin YT, Yi-Feng Chang I, Chung AK, Huang Y, Ueng SH, Hsiao YC, Chien KY, Luo JD, Chen CH, Liao WC, Hung JL, Yuan SN, OuYang CN, Chiang WF, Chien CY, Chuang HC, Chu LJ, Liu H, Yang CY, Robles AI, Rodriguez H, Lin HH, Yang HY, Hsueh C, Chang KP, Yu JS, Chang YS. Integrated multi-omics analyses of oral squamous cell carcinoma reveal precision patient stratification and personalized treatment strategies. Cancer Lett. 2025;614:217482.","journal-title":"Cancer Lett"},{"issue":"10","key":"3663_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/cac2.12194","volume":"41","author":"X Meng","year":"2021","unstructured":"Meng X, Lou QY, Yang WY, Wang YR, Chen R, Wang L, Xu T, Zhang L. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential. Cancer Commun (London England). 2021;41(10):981\u20131006.","journal-title":"Cancer Commun (London England)"},{"key":"3663_CR21","doi-asserted-by":"publisher","first-page":"1402514","DOI":"10.3389\/fphar.2024.1402514","volume":"15","author":"R Chen","year":"2024","unstructured":"Chen R, Zhu S, Zhao R, Liu W, Jin L, Ren X, He H. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma. Front Pharmacol. 2024;15:1402514.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3663_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189\u2013200.","journal-title":"Gut Microbes"},{"issue":"5","key":"3663_CR23","doi-asserted-by":"publisher","first-page":"189150","DOI":"10.1016\/j.bbcan.2024.189150","volume":"1879","author":"MD Asmamaw","year":"2024","unstructured":"Asmamaw MD, He A, Zhang LR, Liu HM, Gao Y. Histone deacetylase complexes: Structure, regulation and function. Biochim Et Biophys Acta Reviews Cancer. 2024;1879(5):189150.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"issue":"4","key":"3663_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/onc.2011.263","volume":"31","author":"L Sun","year":"2012","unstructured":"Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M, Zhang W, Chen W, Pan C, Liu Q, Song E, Li J. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene. 2012;31(4):432\u201345.","journal-title":"Oncogene"},{"issue":"20","key":"3663_CR25","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.7150\/thno.37556","volume":"9","author":"W Chen","year":"2019","unstructured":"Chen W, Wang P, Lu Y, Jin T, Lei X, Liu M, Zhuang P, Liao J, Lin Z, Li B, Peng Y, Pan G, Lv X, Zhang H, Ou Z, Xie S, Lin X, Sun S, Ferrone S, Tannous BA, Ruan Y, Li J, Fan S. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation. Theranostics. 2019;9(20):5739\u201354.","journal-title":"Theranostics"},{"issue":"6","key":"3663_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"52","key":"3663_CR27","doi-asserted-by":"publisher","first-page":"e2412070121","DOI":"10.1073\/pnas.2412070121","volume":"121","author":"H Wang","year":"2024","unstructured":"Wang H, Xu F, Yao C, Dai H, Xu J, Wu B, Tian B, Shi X, Wang C. Engineering bacteria for cancer immunotherapy by inhibiting IDO activity and reprogramming CD8\u2009+\u2009T cell response. Proc Natl Acad Sci USA. 2024;121(52):e2412070121.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"3663_CR28","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","volume":"42","author":"X Wang","year":"2024","unstructured":"Wang X, Fang Y, Liang W, Wong CC, Qin H, Gao Y, Liang M, Song L, Zhang Y, Fan M, Liu C, Lau HC, Xu L, Li X, Song W, Wang J, Wang N, Yang T, Mo M, Zhang X, Fang J, Liao B, Sung JJY, Yu J. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell. 2024;42(10):1729\u2013e17461728.","journal-title":"Cancer Cell"},{"issue":"10","key":"3663_CR29","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1136\/gutjnl-2024-334346","volume":"74","author":"H Hazime","year":"2025","unstructured":"Hazime H, Ducasa GM, Santander AM, Brito N, Gonzalez-Horta EE, Quintero MA, Barnes S, Wilson L, Zhang Y, Yu F, Gharaibeh RZ, Jobin C, Faust KM, Damas OM, Deshpande A, Kerman DH, Proksell S, Pignac-Kobinger J, Fern\u00e1ndez I, Burgue\u00f1o JF, Abreu MT. DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis. Gut. 2025;74(10):1589\u2013601.","journal-title":"Gut"},{"issue":"5","key":"3663_CR30","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR, Fu YX, Chen Y, Guo X. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity. Cell Metab. 2021;33(5):988\u2013e10001007.","journal-title":"Cell Metab"},{"issue":"W1","key":"3663_CR31","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","volume":"50","author":"A Ianevski","year":"2022","unstructured":"Ianevski A, Giri AK, Aittokallio T. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res. 2022;50(W1):W739\u201343.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3663_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng S, Wang W, Aldahdooh J, Malyutina A, Shadbahr T, Tanoli Z, Pessia A, Tang J. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genom Proteom Bioinform. 2022;20(3):587\u201396.","journal-title":"Genom Proteom Bioinform"},{"key":"3663_CR33","doi-asserted-by":"crossref","unstructured":"Menon SS, Guruvayoorappan C, Sakthivel KM, Rasmi RR. Ki-67 protein as a tumour proliferation marker. Clinica chimica acta; international journal of clinical chemistry. 2019;491:39\u201345.","DOI":"10.1016\/j.cca.2019.01.011"},{"key":"3663_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-4598-11-33","volume":"11","author":"Z Sun","year":"2012","unstructured":"Sun Z, Luo Q, Ye D, Chen W, Chen F. Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis. Mol Cancer. 2012;11:33.","journal-title":"Mol Cancer"},{"issue":"7","key":"3663_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/CAD.0b013e3283421f7c","volume":"22","author":"Y Molin","year":"2011","unstructured":"Molin Y, Fayette J. Current chemotherapies for recurrent\/metastatic head and neck cancer. Anticancer Drugs. 2011;22(7):621\u20135.","journal-title":"Anticancer Drugs"},{"issue":"4","key":"3663_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","volume":"27","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem Biology. 2020;27(4):365\u201375.","journal-title":"Cell Chem Biology"},{"issue":"51","key":"3663_CR37","first-page":"e1904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent progress in ferroptosis inducers for cancer Therapy. Advanced materials (Deerfield beach. Fla). 2019;31(51):e1904197.","journal-title":"Fla)"},{"key":"3663_CR38","doi-asserted-by":"publisher","first-page":"154701","DOI":"10.1016\/j.phymed.2023.154701","volume":"112","author":"M Ni","year":"2023","unstructured":"Ni M, Zhou J, Zhu Z, Xu Q, Yin Z, Wang Y, Zheng Z, Zhao H. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe(2+) accumulation. Phytomedicine. 2023;112:154701.","journal-title":"Phytomedicine"},{"key":"3663_CR39","doi-asserted-by":"publisher","first-page":"101977","DOI":"10.1016\/j.redox.2021.101977","volume":"43","author":"Y Sun","year":"2021","unstructured":"Sun Y, Qiao Y, Liu Y, Zhou J, Wang X, Zheng H, Xu Z, Zhang J, Zhou Y, Qian L, Zhang C, Lou H. ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance. Redox Biol. 2021;43:101977.","journal-title":"Redox Biol"},{"issue":"1","key":"3663_CR40","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, Klein M, Wempe A, Leister H, Raifer H, Picard F, Muhammad K, Ohl K, Romero R, Fischer F, Bauer CA, Huber M, Gress TM, Lauth M, Danhof S, Bopp T, Nerreter T, Mulder IE, Steinhoff U, Hudecek M, Visekruna A. Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12(1):4077.","journal-title":"Nat Commun"},{"key":"3663_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","volume":"12","author":"K Pant","year":"2017","unstructured":"Pant K, Yadav AK, Gupta P, Islam R, Saraya A, Venugopal SK. Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells. Redox Biol. 2017;12:340\u20139.","journal-title":"Redox Biol"},{"key":"3663_CR42","doi-asserted-by":"publisher","first-page":"111227","DOI":"10.1016\/j.cbi.2024.111227","volume":"403","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Qin Y, Sun X, Bian Z, Liu L, Liu H, Mao L, Sun S. Sodium butyrate blocks the growth of colorectal cancer by inhibiting the aerobic Glycolysis mediated by SIRT4\/HIF-1\u03b1. Chemico-Biol Interact. 2024;403:111227.","journal-title":"Chemico-Biol Interact"},{"issue":"5","key":"3663_CR43","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.4149\/neo_2022_220311N270","volume":"69","author":"HQ Yue","year":"2022","unstructured":"Yue HQ, Xu PF, Guo YD, Qi J, Liu RM, Li DH. Sodium butyrate inhibits oral squamous cell carcinoma proliferation and invasion by regulating the HDAC1\/HSPB7 axis. Neoplasma. 2022;69(5):1029\u201340.","journal-title":"Neoplasma"},{"key":"3663_CR44","doi-asserted-by":"publisher","first-page":"101274","DOI":"10.1016\/j.drup.2025.101274","volume":"82","author":"T Yang","year":"2025","unstructured":"Yang T, Zhang S, Nie K, Cheng C, Peng X, Huo J, Zhang Y. ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2025;82:101274.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"issue":"1","key":"3663_CR45","doi-asserted-by":"publisher","first-page":"7483","DOI":"10.1038\/s41467-025-62433-2","volume":"16","author":"B Li","year":"2025","unstructured":"Li B, Lin F, Song B, Han S, Ye Z, Sun Y, Wang P, Xia Y, Yu W, Zhou X, Cheng F. The long non-coding RNA RSDR protects against acute kidney injury in mice by interacting with HnRNPK to regulate DHODH-mediated ferroptosis. Nat Commun. 2025;16(1):7483.","journal-title":"Nat Commun"},{"issue":"8","key":"3663_CR46","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s43587-025-00902-5","volume":"5","author":"RS Blanc","year":"2025","unstructured":"Blanc RS, Shah N, Hachmer S, Salama NAS, Meng FW, Mousaei A, Puri G, Hwang JH, Wacker EE, Yang BA, Aguilar CA, Chakkalakal JV, Onukwufor JO, Murphy PJ, Calvi LM, Dilworth FJ, Dirksen RT. Epigenetic erosion of H4K20me1 induced by inflammation drives aged stem cell ferroptosis. Nat Aging. 2025;5(8):1491\u2013509.","journal-title":"Nat Aging"},{"issue":"1","key":"3663_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-025-02170-6","volume":"10","author":"S Ma","year":"2025","unstructured":"Ma S, Wang Z, Xiong Z, Ge Y, Xu MY, Zhang J, Peng Y, Zhang Q, Sun J, Xi Z, Peng H, Xu W, Wang Y, Li L, Zhang C, Chao Z, Wang B, Gao X, Zhang X, Wei GH, Wang Z. Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer. Signal Transduct Target Ther. 2025;10(1):87.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"3663_CR48","doi-asserted-by":"publisher","first-page":"101663","DOI":"10.1016\/j.xcrm.2024.101663","volume":"5","author":"MJ Nokin","year":"2024","unstructured":"Nokin MJ, Darbo E, Richard E, San Jos\u00e9 S, de Hita S, Prouzet-Mauleon V, Turcq B, Gerardelli L, Crake R, Velasco V, Koopmansch B, Lambert F, Xue JY, Sang B, Horne J, Ziemons E, Villanueva A, Blomme A, Herfs M, Cataldo D, Calvayrac O, Porporato P, Nadal E, Lito P, J\u00e4nne PA, Ricciuti B, Awad MM, Ambrogio C. Santamar\u00eda D. In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAF(V600E) lung adenocarcinoma. Cell Rep Med. 2024;5(8):101663.","journal-title":"Cell Rep Med"},{"key":"3663_CR49","doi-asserted-by":"crossref","unstructured":"Kim N, Yang C. Sodium butyrate inhibits the expression of thymidylate synthase and induces cell death in colorectal cancer cells. Int J Mol Sci. 2024;25(3):1572.","DOI":"10.3390\/ijms25031572"},{"issue":"7\u20138","key":"3663_CR50","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s10495-023-01850-4","volume":"28","author":"Z Wang","year":"2023","unstructured":"Wang Z, Shu W, Zhao R, Liu Y, Wang H. Sodium butyrate induces ferroptosis in endometrial cancer cells via the RBM3\/SLC7A11 axis. Apoptosis. 2023;28(7\u20138):1168\u201383.","journal-title":"Apoptosis"},{"issue":"6","key":"3663_CR51","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.7150\/jca.28919","volume":"10","author":"K Huang","year":"2019","unstructured":"Huang K, Liao X, Han C, Wang X, Yu T, Yang C, Liu X, Yu L, Chen Z, Qin W, Zhu G, Su H, Liu Z, Zeng X, Zhou X, Lu S, Huang J, Liang Y, Liu Z, Deng J, Ye X, Peng T. Genetic variants and expression of cytochrome p450 oxidoreductase predict postoperative survival in patients with hepatitis B Virus-Related hepatocellular carcinoma. J Cancer. 2019;10(6):1453\u201365.","journal-title":"J Cancer"},{"issue":"19","key":"3663_CR52","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-15-1107","volume":"75","author":"FW Hunter","year":"2015","unstructured":"Hunter FW, Young RJ, Shalev Z, Vellanki RN, Wang J, Gu Y, Joshi N, Sreebhavan S, Weinreb I, Goldstein DP, Moffat J, Ketela T, Brown KR, Koritzinsky M, Solomon B, Rischin D, Wilson WR, Wouters BG. Identification of P450 oxidoreductase as a major determinant of sensitivity to Hypoxia-Activated prodrugs. Cancer Res. 2015;75(19):4211\u201323.","journal-title":"Cancer Res"},{"key":"3663_CR53","doi-asserted-by":"publisher","first-page":"e15377","DOI":"10.7717\/peerj.15377","volume":"11","author":"V Besskaya","year":"2023","unstructured":"Besskaya V, Zhang H, Bian Y, Liang J, Bi G, Shan G, Zhan C, Lin Z. Hepatic nuclear factor 4 alpha promotes the ferroptosis of lung adenocarcinoma via transcriptional activation of cytochrome P450 oxidoreductase. PeerJ. 2023;11:e15377.","journal-title":"PeerJ"},{"issue":"4","key":"3663_CR54","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012;48(4):612\u201326.","journal-title":"Mol Cell"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03663-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03663-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03663-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:19:33Z","timestamp":1781633973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03663-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3663"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03663-0","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal research was approved by the Laboratory Animal Care and Use Committee of Sun Yat-sen University (Approval Number: SYSU-IACUC-2025-000490).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed with publishing this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}